Norden Group
UTHR icon

Norden Group’s United Therapeutics UTHR Stock Holding History

Norden Group’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$300K Sell
554
-54
-9% -$27.9K 0.02% 512
2026
Q2 		$329K Sell
608
-2
-0.3% -$1.13K 0.03% 496
2026
Q1 		$362K Buy
610
+44
+8% +$21.9K 0.03% 412
2025
Q4 		$276K Buy
+566
New +$264K 0.03% 491

Other funds holding UTHR

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Norden Group's UTHR Position: Q3 2026 in Review

Norden Group reduced its United Therapeutics (UTHR) stake by 8.9% in Q3 2026, selling an estimated $27.9K and leaving 554 shares worth $300K. The position accounts for 0.02% of the portfolio, ranked #512.

Norden Group first reported a position in UTHR in Q4 2025 and has held it in 4 quarters since. The position peaked at $362K in Q1 2026. 673 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.

  • Norden Group held 554 shares of United Therapeutics worth $300K as of Q3 2026.
  • Norden Group sold 54 United Therapeutics shares in Q3 2026, an estimated $27.9K.
  • United Therapeutics made up 0.02% of Norden Group's portfolio in Q3 2026, its #512 holding.
  • Norden Group first reported a position in United Therapeutics in Q4 2025 and has held it in 4 quarters since.
  • Norden Group's United Therapeutics position peaked at $362K in Q1 2026.
  • 673 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.

Based on Norden Group's 13F filing for Q3 2026, filed 20 Oct 2026.